⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7069799 | 0.77 | — | — | |
| SCHEMBL19843687 | 0.74 | — | — | |
| SCHEMBL6433954 | 0.74 | — | — | |
| SCHEMBL10081632 | 0.72 | — | — | |
| SCHEMBL2353387 | 0.72 | — | — | |
| SCHEMBL8714397 | 0.72 | — | — | |
| SCHEMBL7066932 | 0.69 | ALDH1A1 (0.32) | — | |
| SCHEMBL7067762 | 0.69 | — | — | |
| SCHEMBL10709644 | 0.69 | — | — | |
| SCHEMBL28973929 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7236 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024093947-A1 | PRODRUG FOR DELIVERING SIRNA INTO CELL | 大睿生物医药科技(上海)有限公司 | 2024-05-10 | — | — | WO | claimed |
| WO-2024093907-A1 | LIGAND FOR DELIVERING SIRNA TO EYE AND CENTRAL NERVOUS SYSTEM | 大睿生物医药科技(上海)有限公司 | 2024-05-10 | — | — | WO | claimed |
| EP-2991655-B1 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-04-10 | — | — | EP | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| EP-3649135-B1 | SYNTHESIS OF HALICHONDRINS | HARVARD COLLEGE (US) | 2022-12-28 | — | — | EP | claimed |
| US-11241435-B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | THE GENERAL HOSPITAL CORPORATION (US) | 2022-02-08 | — | — | US | claimed |
| EP-3172213-B1 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2021-09-22 | — | — | EP | claimed |
| EP-3092220-B1 | VITAMIN C PRODRUGS AND USES THEREOF | UNIV FLORIDA (US) | 2021-01-20 | — | — | EP | claimed |
| US-10870651-B2 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-12-22 | — | — | US | claimed |
| EP-3171874-B1 | IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2020-11-18 | — | — | EP | claimed |
| US-5142039-A | β-lactam antibiotics | ELI LILLY AND COMPANY (US) | 1992-08-25 | — | — | US | claimed |
| US-5136060-A | Reacting with alcohol | FLORIDA STATE UNIVERSITY (US) | 1992-08-04 | — | — | US | claimed |
| US-5126267-A | Protected hydroxy method for alcohol-ester separation | EASTMAN KODAK COMPANY (US) | 1992-06-30 | — | — | US | claimed |
| EP-0428376-A1 | Method for preparation of taxol using an oxazinone | FLORIDA STATE UNIVERSITY (US) | 1991-05-22 | — | — | EP | claimed |
| US-5015744-A | Esterification of an alcohol with an oxazinone | FLORIDA STATE UNIVERSITY (US) | 1991-05-14 | — | — | US | claimed |
| EP-0400971-A2 | Method for preparation of taxol | FLORIDA STATE UNIVERSITY (US) | 1990-12-05 | — | — | EP | claimed |
| US-4381300-A | Sulphur analogs of cephalosporins having a nucleophile substituted in the 7 position | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1983-04-26 | — | — | US | claimed |
| US-4265882-A | Sulphur analogs of penicillins having a nucleophile substituted in the 6 and 7 position, respectively | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-05-05 | — | — | US | claimed |
| EP-0000800-B1 | SELECTIVE N-PROTECTION OF AMINOGLYCOSIDES AND NOVEL, SELECTIVELY PROTECTED AMINOGLYCOSIDE INTERMEDIATES | Technobiotic Ltd. (CH) | 1980-12-10 | — | — | EP | claimed |
| US-4066752-A | 1-Desamino-1-hydroxy and 1-desamino-1-epi-hydroxy-4,6-di-o-(aminoglycosyl)-1,3-diaminocyclitols; 1-desamino-1-oxo-4,6-di-o-(aminoglycosyl)-1,3-diaminocyclitols, intermediates and use as antibacterial agents | SCHERING CORPORATION (US) | 1978-01-03 | — | — | US | claimed |